Obesity as a prognostic factor in chronic symptomatic heart failure

被引:70
|
作者
Bozkurt, B
Deswal, A
机构
[1] Michael E DeBakey Vet Affairs Med Ctr, Dept Med, Cardiol Sect, Houston, TX USA
[2] Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA
[3] Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA
关键词
D O I
10.1016/j.ahj.2005.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Obesity is considered as an independent risk factor for development of heart failure (HF); however, its role in the progression of HF independent of atherosclerotic heart disease, hypertension, and diabetes is not well described. Methods To identify the role of obesity in HF outcomes, we analyzed the Digitalis Investigation, Group database with 7788 patients with chronic stable HF. Subjects with body mass index of >= 18.5 and <25 kg/m(2) were categorized as normal weight, >= 25.0 and <30 kg/m2 as overweight, and >= 30.0 kg/m2 as obese. Results Compared with normal weight,, overweight or obese patients had lower all-cause mortality (37.8%, 32.4%, and 28.5%, P < .0001) and lower HF mortality (38.7%, 31.2%, and 33.6%, P = .01). After adjustment for differences in baseline characteristics, the overweight (HR 0.87, 95% CI 0.79-0.95, P = .002) and the obese (HR 0.82, 95% CI 0.73-0.92, P = .0005) had better survival rates compared with normal-weight groups. Similarly, the overweight (HR 0.76, 95% CI 0.65-0.88, P = .0003) or the obese (HR 0.79, 95% CI 0.63-0.88, P = .005) patients had better HF survival rates. After adjustment for baseline differences, the rate of hospitalizations was similar in the 3 groups. Conclusions in patients with chronic symptomatic HF, obesity or overweight status was associated with a lower risk for mortality but a similar risk for hospitalization compared with normal weight status. Prospective studies evaluating the risks and benefits of sustenance of obesity or weight loss are needed in this population.
引用
收藏
页码:1233 / 1238
页数:6
相关论文
共 50 条
  • [1] Serum cholinesterase is an important prognostic factor in chronic heart failure
    Takamasa Sato
    Hiroyuki Yamauchi
    Satoshi Suzuki
    Akiomi Yoshihisa
    Takayoshi Yamaki
    Koichi Sugimoto
    Hiroyuki Kunii
    Kazuhiko Nakazato
    Hitoshi Suzuki
    Shu-ichi Saitoh
    Yasuchika Takeishi
    Heart and Vessels, 2015, 30 : 204 - 210
  • [2] Serum cholinesterase is an important prognostic factor in chronic heart failure
    Sato, Takamasa
    Yamauchi, Hiroyuki
    Suzuki, Satoshi
    Yoshihisa, Akiomi
    Yamaki, Takayoshi
    Sugimoto, Koichi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Suzuki, Hitoshi
    Saitoh, Shu-ichi
    Takeishi, Yasuchika
    HEART AND VESSELS, 2015, 30 (02) : 204 - 210
  • [3] Serum urate as a prognostic factor in patients with chronic heart failure
    Kemp, M
    Donovan, J
    Hooper, J
    CLINICA CHIMICA ACTA, 2005, 355 : S117 - S117
  • [4] Prognostic factor of heart failure
    Yoshihiro, I
    Akira, T
    Kaoru, T
    Katsumi, O
    Katsunort, O
    Kazuo, M
    Shin-Ichiro, Y
    Kohei, Y
    Takatoshi, H
    Teishi, K
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S172 - S172
  • [5] Hyperhomocysteinemia in patients with symptomatic chronic heart failure: Prevalence and prognostic importance - pilot study
    Naruszewicz, Marek
    Jankowska, Ewa A.
    Zymlinski, Robert
    Bukowska, Hanna
    Millo, Barbara
    Banasiak, Waldemar
    Ponikowski, Piotr
    ATHEROSCLEROSIS, 2007, 194 (02) : 408 - 414
  • [6] Plasma renin activity is an independent prognostic factor in chronic heart failure
    Vergaro, G.
    Fontana, M.
    Poletti, R.
    Giannoni, A.
    Iervasi, A. L.
    Masi, L.
    Mammini, C.
    Gabutti, A.
    Passino, C.
    Emdin, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 393 - 393
  • [7] Empagliflozin: A Review in Symptomatic Chronic Heart Failure
    James E. Frampton
    Drugs, 2022, 82 : 1591 - 1602
  • [8] Prognostic importance of deceleration time in symptomatic heart failure
    Akkan, D.
    Kjaergaard, J.
    Moller, J. E.
    Hassager, C.
    Torp-Pedersen, C.
    Kober, L.
    EUROPEAN HEART JOURNAL, 2007, 28 : 420 - 420
  • [9] Empagliflozin: A Review in Symptomatic Chronic Heart Failure
    Frampton, James E.
    DRUGS, 2022, 82 (16) : 1591 - 1602
  • [10] Obesity and survival in chronic heart failure
    Davos, CH
    Doehner, W
    Rauchhaus, M
    Cicoira, M
    Francis, DP
    Anker, SD
    CIRCULATION, 2000, 102 (18) : 876 - 876